Borrelia infection and risk of non-Hodgkin lymphoma

Blood

Volumn 111, Issue 12, 2008, Pages 5524-5529

  Schöllkopf, Claudia ^a   Melbye, Mads ^a   Munksgaard, Lars ^b   Smedby, Karin Ekström ^c   Rostgaard, Klaus ^a   Glimelius, Bengt ^c,d   Chang, Ellen T ^e,f   Roos, Göran ^g   Hansen, Mads ^b   Adami, Hans Olov ^c,h   Hjalgrim, Henrik ^a  

^a STATENS SERUM INSTITUT   (Denmark)

^b Rigshospitalet   (Denmark)

^c KAROLINSKA INSTITUTE   (Sweden)

^d UPPSALA UNIVERSITY   (Sweden)

^e NORTHERN CALIFORNIA CANCER CENTER   (United States)

^f STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^h HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM ANTIBODY; BORRELIA ANTIBODY; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BORRELIA BURGDORFERI; BORRELIA INFECTION; CANCER RISK; CARCINOGENESIS; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MANTLE CELL LYMPHOMA; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; TICK BITE; ADOLESCENT; ANIMAL; BITES AND STINGS; BLOOD; IMMUNOLOGY; INCIDENCE; ISOLATION AND PURIFICATION; LYME DISEASE; MICROBIOLOGY; MIDDLE AGED; RISK FACTOR; TICK;

ADOLESCENT; ADULT; AGED; ANIMALS; ANTIBODIES, BACTERIAL; BITES AND STINGS; BORRELIA BURGDORFERI; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INCIDENCE; LYME DISEASE; LYMPHOMA, MANTLE-CELL; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; RISK FACTORS; TICKS;

EID: 47049086604     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2007-08-109611     Document Type: Article

References (52)

1. Ferreri AJ, Guidoboni M, Ponzoni M, et al. Evidence for an association between Chlamydia psittaci and ocular adnexal lymphomas. J Natl Cancer Inst. 2004;96:586-594.
2. Dal Maso L Franceschi S. Hepatitis C virus and risk of lymphoma and other lymphoid neoplasms: a meta-analysis of epidemiologic studies. Cancer Epidemiol Biomarkers Prev. 2006;15:2078-2085.
3. Lecuit M, Abachin E, Martin A, et al. Immunopro-liferative small intestinal disease associated with Campylobacterjejuni. N Engl J Med. 2004;350:239-248.
4. De Sanjose S, Dickie A, Alvaro T, et al. Helicobacter pylori and malignant lymphoma in Spain. Cancer Epidemiol Biomarkers Prev. 2004;13:944-948.
5. Stanek G, Strle F. Lyme borreliosis. Lancet. 2003;362:1639-1647.
6. Asbrink E, Hovmark A, Hederstedt B. The spirochetal etiology of acrodermatitis chronica atrophicans Herxheimer. Acta Derm Venereol. 1984;64:506-512.
7. Du MQ, Isaccson PG. Gastric MALT lymphoma: from aetiology to treatment. Lancet Oncol. 2002;3:97-104.
8. Garbe C, Stein H, Gollnick H. Taud W. Orfanos CE. [Cutaneous B cell lymphoma in chronic Borrelia burgdorferi infection: report of 2 cases and a review of the literature]. Hautarzt. 1988;39:717-726.
9. Garbe C, Stein H, Dienemann D, Orfanos CE. Borrelia burgdorferi- associated cutaneous B cell lymphoma: clinical and immunohistologic characterization of four cases. J Am Acad Dermatol. 1991;24:584-590.
10. Jelic S, Filipovic-Ljeskovic I. Positive serology for
11. Lyme disease borrelias in primary cutaneous B-cell lymphoma: a study in 22 patients: is it a fortuitous finding? Hematol Oncol. 1999;17:107-116.
12. Cerroni L Zochling N, Putz B, Kerl H. Infection by Borrelia burgdorferi and cutaneous B-cell lymphoma. J Cutan Pathol. 1997;24:457-461.
13. Goodlad JR, Davidson MM, Hollowood K, et al. Primary cutaneous B-cell lymphoma and Borrelia burgdorferi infection in patients from the Highlands of Scotland. Am J Surg Pathol. 2000;24:1279-1285.
14. Kutting B, Bonsmann G, Metze D, Luger TA, Cerroni L. Borrelia burgdorferi-associated primary cutaneous B cell lymphoma: complete clearing of skin lesions after antibiotic pulse therapy or intralesional injection of interferon alfa-2a. J Am Acad Dermatol. 1997:36:311-314.
15. Roggero E, Zucca E, Mainetti C, et al. Eradication
16. of Borrelia burgdorferi infection in primary marginal zone B-cell lymphoma of the skin. Hum Pathol. 2000;31:263-268.
17. Steere AC. Lyme disease. N Engl J Med. 2001;345:115-125.
18. Munksgaard L, Obitz ER, Goodlad JR, et al. Demonstration of B. burgdorferi-DNA in two cases of nodal lymphoma. Leuk Lymphoma. 2004;45:1721-1723.
19. Smedby KE. Hjalgrim H, Melbye M, et al. Ultraviolet radiation exposure and risk of malignant lymphomas. J Natl Cancer Inst. 2005:97:199-209.
20. d'Amore F, Christensen BE. Brincker H. et al. Clinicopathological features and prognostic factors in extranodal non-Hodgkin lymphomas: Danish LYFO Study Group. Eur J Cancer. 1991;27:1201-1208.
21. World Health Organization Classification of Tumours. In: Jaffe ES, Harris NL, Stein H, Vardiman J. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2001:10-302.
22. Hartge R Wang SS, Bracci PM, Devesa SS, Holly EA. Non-Hodgkin Lymphoma. In: Schottenfeld D. Fraumeni JF Jr, eds. Cancer Epidemiology and Prevention. New York, NY: Oxford University Press; 2006:898-918.
23. Burgdorfer W, Barbour AG, Hayes SF et al. Lyme disease-a tick-borne spirochetosis? Science. 1982;216:1317-1319.
24. Grassner H, Janner M. [Acrodermatitis chronica atrophicans Herxheimer in combination with cutaneous lymphoma]. Hautarzt. 1974;25:453-456.
25. Langer H. [Acrodermatitis chronica atrophicans (Herxheimer) and lymphoreticular tumors of the skin.]. Dtsch Gesundheitsw. 1959;14:1800-1803.
26. Tothova SM, Bonin S, Trevisan G, Stanta G. Mycosis fungoides: is it a Borrelia burgdorferi-associated disease? Br J Cancer. 2006;94:879-883.
27. Leboit PE, McNutt NS, Reed JA, Jacobson M, Weiss LM. Primary cutaneous immunocytoma: a B-cell lymphoma that can easily be mistaken for cutaneous lymphoid hyperplasia. Am J Surg Pathol. 1994;18:969-978.
28. Li C, Inagaki H, Kuo TT. et al. Primary cutaneous marginal zone B-cell lymphoma: a molecular and clinicopathologic study of 24 asian cases. Am J Surg Pathol. 2003;27:1061-1069.
29. Wood GS. Kamath NV, Guitart J, et al. Absence of Borrelia burgdorferi DNA in cutaneous B-cell lymphomas from the United States. J Cutan Pathol. 2001;28:502-507.
30. Bogle MA, Riddle CC, Triana EM, Jones D, Duvic M. Primary cutaneous B-cell lymphoma. J Am Acad Dermatol. 2005;53:479-484.
31. Cerroni L Hofler G, Back B, et al. Specific cutaneous infiltrates of B-cell chronic lymphocytic leukemia (B-CLL) at sites typical for Borrelia burgdorferi infection. J Cutan Pathol. 2002;29:142-147.
32. Suarez F. Lortholary O. Hermine O, et al. Infection-associated lymphomas derived from marginal zone B cells: a model of antigen-driven lymphoproliferation. Blood. 2006;107:3034-3044.
33. Levine AM, Shimodaira S, Lai MM. Treatment of HGV-related mantle-cell lymphoma with ribavirin and pegylated interferon Alfa. N Engl J Med. 2003;349:2078-2079.
34. Jares P, Colomer D. Campo E. Genetic and molecular pathogenesis of mantle cell lymphoma: perspectives for new targeted therapeutics. Nature Rev Cancer. 2007;7:750-762.
35. Ekerfelt C, Masreliez C, Svenvik M, et al. Antibodies and T-cell reactivity to Borrelia burgdorferi in an asymptomatic population: a study of healthy blood donors in an inland town district in the south-east of Sweden. Scand J Infect Dis. 2001;33:806-808.
36. Ekerfelt C, Forsberg P, Svenvik M, et al. Asymptomatic Borrelia-seropositive individuals display the same incidence of Borrelia-specific interferon-gamma (IFN-gamma)-secreting cells in blood as patients with clinical Borrelia infection. Clin Exp Immunol. 1999;115:498-502.
37. Singh SK, Girschick HJ. Molecular survival strategies of the Lyme disease spirochete Borrelia burgdorferi. Lancet Infect Dis. 2004;4:575-583.
38. Widhe M, Jarefors S, Ekerfelt C, et al. Borrelia-specific interferon-gamma and interleukin-4 secretion in cerebrospinal fluid and blood during Lyme borreliosis in humans: association with clinical outcome. J Infect Dis. 2004;189:1881-1891.
39. Mullegger RR, McHugh G, Ruthazer R, et al. Differential expression of cytokine mRNA in skin specimens from patients with erythema migrans or acrodermatitis chronica atrophicans. J Invest Dermatol. 2000;115:1115-1123.
40. Romagnani S. Th1/Th2 cells. Inflamm Bowel Dis. 1999;5:285-294.
41. Baecklund E, Iliadou A, Askling J, et al. Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis. Arthritis Rheum. 2006;54:692-701.
42. Smedby KE, Hjalgrim H, Askling J, et al. Autoimmune and chronic inflammatory disorders and risk of non-Hodgkin lymphoma by subtype. J Natl Cancer Inst. 2006;98:51-60.
43. Hauer AC, Finn TM, MacDonald TT, Spencer J, Isaacson PG. Analysis of TH1 and TH2 cytokine production in low grade B cell gastric MALT-type lymphomas stimulated in vitro with Helicobacter pylori. J Clin Pathol. 1997;50:957-959.
44. Munksgaard L, Frisch M. Melbye M, Hjalgrim H. Incidence patterns of lyme disease and cutaneous B-cell non-Hodgkin's lymphoma in the United States. Dermatology. 2000;201:351-352.
45. Strle F, Nadelman RB, Cimperman J. et al. Comparison of culture-confirmed erythema migrans caused by Borrelia burgdorferi sensu stricto in New York State and by Borrelia afzelii in Slovenia. Ann Intern Med. 1999;130:32-36.
46. Dessau RB, Bangsborg JM, Ejlertsen T, et al. Lyme disease: Glinical characteristics, diagnosis, and treatment. A consensus report. Ugeskr Laeger. 2006:1-34.
47. Berglund J, Eitrem R, Ornstein K, et al. An epidemiologic study of Lyme disease in southern Sweden. N Engl J Med. 1995;333:1319-1327.
48. Hammers-Berggren S. Lebech AM, Karlsson M. et al. Serological follow-up after treatment of patients with erythema migrans and neuroborreliosis. J Clin Microbiol. 1994;32:1519-1525.
49. Lomholt H, Lebech AM, Hansen K, Brandrup F, Halkier-Sorensen L. Long-term serological follow-up of patients treated for chronic cutaneous borreliosis or culture-positive erythema migrans. Acta Derm Venereol. 2000;80:362-366.
50. Aguero-Rosenfeld ME, Wang G, Schwartz I, Wormser GP. Diagnosis of lyme borreliosis. Clin Microbiol Rev. 2005;18:484-509.
51. Hansen K, Hindersson P, Pedersen NS. Measurement of antibodies to the Borrelia burgdorferi flagellum improves serodiagnosis in Lyme disease. J Clin Microbiol. 1988;26:338-346.
52. Panelius J, Lahdenne P, Saxen H, Heikkila T, Seppala I. Recombinant flagellin A proteins from Borrelia burgdorferi sensu stricto, B. afzelii, and B. garinii in serodiagnosis of Lyme borreliosis. J Clin Microbiol. 2001:39:4013-4019.